Key facts
- It has raised $7.4M; the latest was Later Stage VC in Dec 2025.
- Notable investors include Jolmo Investment, Legend Star, Lead Wealth Capital, Ming Bioventures, Nanjing Gaoke Company — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Help Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Help Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Help Therapeutics
Researcher and developer of human stem cell regeneration drugs. The company specializes in developing bioengineered stem cell regeneration products including artificially induced pluripotent stem cells, disease-specific cardiomyocytes, somatic reprogramming and manual diaphragm clamps, aiming to provide high-quality research solutions to support regenerative treatments for liver, pancreas, nerves and other related diseases.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2016
- Employees
- 6
- Website
- helptherapeutics.com/
- Ownership
- Privately Held (backing)
Help Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Help Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Help Therapeutics in its N-PORT filings yet. We sweep new filings monthly.